A detailed history of Glenmede Trust CO Na transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 381,168 shares of EW stock, worth $25.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
381,168
Previous 359,663 5.98%
Holding current value
$25.2 Million
Previous $33.2 Million 24.29%
% of portfolio
0.12%
Previous 0.17%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $1.28 Million - $2.02 Million
21,505 Added 5.98%
381,168 $25.2 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $74,436 - $83,275
-883 Reduced 0.24%
359,663 $33.2 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $86,612 - $114,098
1,194 Added 0.33%
360,546 $34.5 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $82,567 - $104,042
-1,338 Reduced 0.37%
359,352 $27.4 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $55,216 - $74,423
-797 Reduced 0.22%
360,690 $25 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $567,197 - $645,487
-7,638 Reduced 2.07%
361,487 $29.9 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $9.11 Million - $11.7 Million
-133,351 Reduced 26.54%
369,125 $27.5 Million
Q3 2022

Nov 16, 2022

BUY
$82.37 - $107.29 $265,972 - $346,439
3,229 Added 0.65%
502,476 $41.5 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $11.4 Million - $17 Million
132,316 Added 36.06%
499,247 $47.5 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $74,532 - $93,816
-731 Reduced 0.2%
366,931 $43.2 Million
Q4 2021

Feb 15, 2022

SELL
$106.37 - $130.68 $97,754 - $120,094
-919 Reduced 0.25%
367,662 $47.6 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $993,184 - $1.18 Million
-9,651 Reduced 2.55%
368,581 $41.7 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $775,016 - $968,401
-9,244 Reduced 2.39%
378,232 $39.2 Million
Q1 2021

May 18, 2021

SELL
$78.68 - $90.67 $205,118 - $236,376
-2,607 Reduced 0.67%
387,476 $32.4 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $144,742 - $184,193
-2,019 Reduced 0.51%
390,083 $35.6 Million
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $158,501 - $206,270
2,359 Added 0.61%
392,102 $31.3 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $14.8 Million - $19.8 Million
257,188 Added 194.02%
389,743 $26.9 Million
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $342,510 - $392,143
4,777 Added 3.74%
132,555 $30.9 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $1.13 Million - $1.39 Million
-18,364 Reduced 12.57%
127,778 $28.1 Million
Q2 2019

Aug 13, 2019

BUY
$55.74 - $64.41 $211,031 - $243,856
3,786 Added 2.66%
146,142 $27 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $14.7 Million - $19.6 Million
-306,058 Reduced 68.25%
142,356 $27.2 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $14 Million - $17.2 Million
301,497 Added 205.22%
448,414 $68.7 Million
Q3 2018

Nov 15, 2018

SELL
$45.7 - $58.03 $184,719 - $234,557
-4,042 Reduced 2.68%
146,917 $25.6 Million
Q2 2018

Aug 15, 2018

BUY
$42.45 - $51.3 $317,610 - $383,826
7,482 Added 5.21%
150,959 $22 Million
Q4 2017

Feb 15, 2018

BUY
$33.79 - $39.39 $20,780 - $24,224
615 Added 0.43%
143,477 $16.2 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $5.18 Million - $5.55 Million
142,862
142,862 $0

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.